Half-year results 2022

Half-year results 2022

Galenica grows strongly in the first half of 2022.

Welcome to Galenica

Welcome to Galenica

Galenica - Health and wellbeing are at the heart of what we do.

Complementary medicine portfolio

Complementary medicine portfolio

The Galenica subsidiary Verfora will acquire 100% of Padma Ltd. at the end of January.

2022 sales

2022 sales

Galenica achieves sales of more than CHF 4 billion for the first time thanks to strong growth.

Daniela Bosshardt

2023 Annual General Meeting

Change to the Board of Directors of the Galenica Group.

Satisfying prospects

Satisfying prospects

Do you want to make a difference? At Galenica, your talent is in safe hands.

Press releases

Verfora continues to expand its complementary medicine portfolio
Press release, Tuesday, 31 January 2023

News

Galenica invests in salary adjustments and attractiveness as an employer
Tuesday, 8 November 2022

Financial Calendar

Date	Event
07.03.2023	Publication of the 2022 results for the Galenica Group

All corporate Termine

Investors

Galenica N	74.35 CHF
Change	+1.16 %
	+0.85 CHF
Volume	102'736
Marketcap	3.72 Mrd

08.02.2023 - T17:30:05